Home | Contact | Sitemap | Restricted area
Phase I
Iris Pharma is specialized in ocular drug development. Over the last 10 years, we have managed 22 phase I clinical studies (with 900 subjects) of the following types:
- First administration in human (first-in-man studies)
- Ocular and systemic safety
- Ocular and systemic pharmacokinetics/pharmacodynamics
- Multiple dose tolerance
- Bioavailability
- Bioequivalence
- Dose finding
Iris Pharma performs the phase 1 ocular trials in a specialized French site wich has high recruitment potential and is compliant with GCP.
We offer partial or full-service phase 1 clinical trial monitoring and project management depending on your specific requirements.
Fields of expertise
• Glaucoma/Ocular hypertension
• Dry eye syndrome, Gougerot-Sjögren syndrome
• Retinal disorders (Age-related Macular Degeneration (AMD or ARMD))
• Diabetic retinopathy
• Eye socket disorders (infection, inflammation)
• Ocular allergy
• Cataract Surgery (LASIK PRK)
• Conjunctival disorders (allergic conjunctivitis, keratoconjunctivitis Sicca, trachoma…)
• Orphan disease
• Medical devices
• Contactology
• Post surgical Inflammation
• Ocular rosacea
Copyright 2008 © Iris Pharma - Conception CKC-Net.com